![]() |
Volumn 10, Issue 4, 1999, Pages 377-384
|
The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer
a
a
|
Author keywords
Anastrozole; Aromatase inhibitors; Breast cancer; Hormonal therapy; Letrozole; Review; Vorozole
|
Indexed keywords
AMINOGLUTETHIMIDE;
ANASTROZOLE;
AROMATASE INHIBITOR;
LETROZOLE;
MEGESTROL ACETATE;
VOROZOLE;
ADVANCED CANCER;
BREAST CARCINOMA;
CANCER PALLIATIVE THERAPY;
DOSE RESPONSE;
DRUG CHOICE;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SELECTIVITY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
MAJOR CLINICAL STUDY;
METASTASIS;
OBESITY;
ORAL DRUG ADMINISTRATION;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RASH;
REVIEW;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BELGIUM;
BREAST NEOPLASMS;
CLINICAL TRIALS;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM METASTASIS;
NITRILES;
POSTMENOPAUSE;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
TAMOXIFEN;
TREATMENT OUTCOME;
TRIAZOLES;
|
EID: 0032907539
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008368300827 Document Type: Review |
Times cited : (121)
|
References (1)
|